Tyler Dylan-Hyde, Chief Legal Officer at CRISPR Therapeutics AG (CRSP), sold 28,210 shares at $18.56 ($524K) on 2017-08-07, disclosed to the SEC on 2017-08-08.
Open-market sale of $524k CRSP by Chief Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.55 | 477 | $9K | 1.7% |
| 2 | $18.56 | 13,210 | $245K | 46.8% |
| 3 | $18.56 | 13,210 | $245K | 46.8% |
| 4 | $18.60 | 1,313 | $24K | 4.7% |
| Total | $18.56 avg | 28,210 | $524K | 100% |
| Filing → |
| CRSP | SELL | 2018-01-02 | $840K | — | Filing → |
| CRSP | SELL | 2017-12-27 | $308K | — | Filing → |
| CRSP | SELL | 2017-12-19 | $284K | — | Filing → |